BTMD Key Statistics, Chart & Performance
The current stock price of BTMD is 2.79 USD. In the past month the price increased by 3.95%. In the past year, price decreased by -56.09%.
BTMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 48.92 | 1.02T | ||
| JNJ | JOHNSON & JOHNSON | 19.99 | 499.98B | ||
| MRK | MERCK & CO. INC. | 12.07 | 263.99B | ||
| PFE | PFIZER INC | 7.83 | 142.51B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.32 | 111.15B | ||
| ZTS | ZOETIS INC | 19.76 | 55.20B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.59 | 22.74B | ||
| VTRS | VIATRIS INC | 5.33 | 14.29B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.34 | 11.13B | ||
| CORT | CORCEPT THERAPEUTICS INC | 95.15 | 8.81B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.81B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.44B |
Related stock screener links
About BTMD
Company Profile
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Company Info
BIOTE CORP -A
1875 W. Walnut Hill Ln #100, Floor 5
Irving TEXAS US
Employees: 217
Phone: 19724869346
BIOTE CORP -A / BTMD FAQ
Can you describe the business of BIOTE CORP -A?
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
What is the stock price of BIOTE CORP -A today?
The current stock price of BTMD is 2.79 USD. The price increased by 6.08% in the last trading session.
What is the dividend status of BIOTE CORP -A?
BTMD does not pay a dividend.
What is the ChartMill rating of BIOTE CORP -A stock?
BTMD has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is BTMD stock listed?
BTMD stock is listed on the Nasdaq exchange.
How is the valuation of BIOTE CORP -A (BTMD) based on its PE ratio?
The PE ratio for BIOTE CORP -A (BTMD) is 3.21. This is based on the reported non-GAAP earnings per share of 0.87 and the current share price of 2.79 USD.
Can you provide the short interest for BTMD stock?
The outstanding short interest for BIOTE CORP -A (BTMD) is 3.78% of its float.
BTMD Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BTMD. When comparing the yearly performance of all stocks, BTMD is a bad performer in the overall market: 90.45% of all stocks are doing better.
BTMD Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BTMD. BTMD has an average financial health and profitability rating.
BTMD Financial Highlights
Over the last trailing twelve months BTMD reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS increased by 190% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.72% | ||
| ROA | 25.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BTMD Forecast & Estimates
For the next year, analysts expect an EPS growth of 229.18% and a revenue growth -3.44% for BTMD